Introduction
Diabetes Reversal Group (DRG) has the only Patented system in the world that reverses Type 2 Diabetes. They have been in business for 15 years, have over 32 million in revenue and they are ready to scale globally.
Our Mission
The mission of DRG is to reverse Type 2 Diabetes in millions of people around the world. The Founder’s aunt Lily died of diabetes complications at the age of 34 and this tragedy led him to develop the current DRG program. 420 million people around the world have diabetes and 99% of them have no idea their disease is reversible, which is causing millions of unnecessary deaths every year. Diabetes is a 966 billion dollar a year industry and growing every year and DRG is poised to be the leader in diabetes reversal.
The Company and Management
DRG was founded in 2009 by Dr. J. Murray Hockings after seeing that a major need existed to help Type 2 Diabetics reverse their disease, since medical physicians aren’t trained how to do it. Dr. Hockings has 33 years of experience in wellness care, is a published author, has given over 425 diabetes seminars since 2009 in 6 countries and is the creator of the world’s only Patented Type 2 Diabetes Reversal System... and their system guarantees results. Their Chief Medical Officer is Kristine Burke, M.D., who is triple board certified in family medicine, integrative medicine and sports medicine and she is a specialist in Chronic Disease Reversal, with 29 years of experience. Their Medical Director is Charles Timson, M.D., who is a Fellow of the American Academy of Family Physicians (FAAFP) and is board certified in family medicine, with 39 years experience. Their Chief Operating Officer is Michelle Giudice, B.S, M.A., and she has been with DRG since 2013.
Our Product
DRG provides a proven, patented method for reversing Type 2 Diabetes by showing patients what to eat and not eat, providing nutritional supplements and exercise recommendations. When patients follow the program as directed, they are able to eliminate their diabetic medications and reverse their disease. Patients are put on a 3, 5 or 7 month program, based on the severity of their diabetes. The program consists of the following:
• Proprietary Enjoy/Avoid List of what to eat and drink
• Proprietary nutritional supplements
• Exercise recommendations
• Before and After lab report
• Weekly meal plans
• Weekly training videos
• Over 240 recipes
• Shopping list
• Weekly group support call
• Monthly newsletter
• Unlimited 1 on 1 support & coaching 5 days a week by phone or email from support
This is an elective procedure, not covered by insurance, so patients pay by credit card or choose to finance the program with one of our 3rd party finance companies. The cost is between 1k-9k, depending on what plan the patient chooses... similar to the cost of braces on crooked teeth, hearing aids or cosmetic dentistry. Monthly payments can start as low as $65/month, which makes our program affordable to anyone who wants to do it.
DRG History
• 2009-2017 – Dr. Hockings gave over 425 diabetes reversal seminars in 6 countries (US, Canada, UK, Australia, New Zealand, Dubai) proving their concept and ensuring they could reproducibly reverse Type 2 Diabetes – generated over 15 million in revenue.
• 2017 – After finalizing their proof of concept, they applied for their Patent.
• 2018 – Opened first clinic in Dallas - finished the year with 6 clinics and 2.7 million in revenue.
• 2019 – Opened 11 more clinics and ended year with over 11.6 million in revenue and plans to open more clinics for a total of 30.
• 2020 – Covid hit and we were forced to close all 17 clinics (we weren’t considered essential) and stop plans on additional clinic expansion.
• 2020 – Received Patent approval - only Patented system in the world that reverses Type 2 Diabetes.
• 2021 – Since we had to close all clinics permanently, we pivoted to a digital/ telemedicine platform where patients can join our program through our online system.
• 2021 – Changed our name from Help Your Diabetes (HYD) to Diabetes Reversal Group (DRG) to more accurately state what we do since receiving our Patent approval. Brought on Kristine Burke, M.D and Charles Timson, M.D. to be our Chief Medical Officer and Medical Director, respectively.
• 2022 – upgraded our digital/telemedicine sales system to allow us to scale faster and increase sales.
• 2023 – rolled out our digital/ telemedicine platform after testing completed.
Our Competitive Advantage
We are the only company in the world with a Patented Type 2 Diabetes Reversal System. We received our Patent in September 8, 2020. (US Patent No. 10,765,318) We also guarantee results... after following our program as directed, if the patient hasn’t reversed their diabetes (A1c under 6.0 taking no diabetic meds) they get a 100% refund plus $1,000 just for trying it. No other company has a Patent or offers this type of guarantee. To qualify for the guarantee, patients have to check in at least once a week to let us know how their blood sugar is doing and they need to send in a daily food log once a week to ensure compliance.
Additional Services In Development
• Type 1 Diabetes Management – recurring revenue
• Pre-diabetes Management – recurring revenue
• Blood Sugar Control Supplement – recurring revenue
• Meal Replacement Drink – recurring revenue
Competition
We only have one competitor in our space, Virta Health, which also does diabetes reversal. The major differences between our companies are:
• They have no Patented system
• They don’t guarantee results
• They don’t provide nutritional supplements to speed, maximize healing & create monthly residual
• Comparing their 12 month study & our 4.5 month study - our results are the same or better (we get quicker results)
• Their definition of diabetes reversal isn’t a clinical reversal. They say diabetes is reversed if your A1C is 6.5 or lower and you are still taking the diabetic medication, Metformin. True clinical reversal of diabetes is an A1C that is 5.9 or lower taking no diabetic medications and that is the definition we use.
Here is Virta Health’s latest series E raise in April 2021 for 133 million bringing total raised to 364 million and 2 billion valuation. https://www.fiercebiotech.com/medtech/virta-health-hits-2b-valuation-133m-funding-to-expand-reach-diabetes-reversing-platform
Their total raise of 364 million shows the tremendous interest in the diabetes reversal space.
Here is a new article showing how the weight loss giant NOOM, just secured 540 million of capital to expand into diabetes, high blood pressure and other chronic diseases. https://www.fiercehealthcare.com/digital-health/weight-loss-app-noom-hauls-540m-to-expand-into-diabetes-hypertension They aren't doing diabetes reversal, just management, but this is further proof of the high interest in the diabetes space.
Neither Virta Health nor NOOM have a patented system to reverse Type 2 Diabetes... only we do, which puts us in a great position competitively as we start to scale rapidly.
Financial Consideration
We are projecting sales of 1 million/month by end July 2024 and 5 million per month by end of 2024 even if we don’t raise any capital. The capital we are requesting will allow us to scale much faster. This revenue will be generated from:
• Direct to consumer sales through national radio, TV, newspaper, magazine and digital marketing.
• Combination of Doctors as Distributors and Affiliates, all promoting DRG
• Licensing deal with weight loss companies (Weight Watchers, NutriSystem or NOOM).
• Licensing deal with a Pharmaceutical company that wants to offer Type 2 Diabetes Reversal options.
• Strategic alliances with social media influencers, diabetic supply companies (Dexcom) and health care companies with large databases.
• Additional services listed above.
Websites
Our main website is www.DiabetesReversalGroup.com Our sales website is www.ReverseYourDiabetes.com
Financing Requirements & Use of Funds
We are seeking up to 50 million in capital in equity/debt hybrid. Maximum of 15% equity at a 100 million valuation. This capital will be used to help us expand globally and take advantage of our Patent and Digital Platform, so we can capture as much market share as possible, as quickly as possible. The capital will be used for marketing, expansion, app development, onboarding more distributors and to ensure hiring of additional support staff to handle the expansion demands.
Conclusion
DRG has the only Patented solution for one of the world’s leading diseases and has a 15-year proven track record with over 32 million in revenue to date. With the capital we’re seeking and the right partnership, we are poised to dominate the diabetes reversal space globally, while earning incredible returns for our investors.
For More Information, Please Contact:
Jay Bergin – VP of Investor Relations
(866) 460-4644
Jay@DiabetesReversalGroup.com